Pharmacoeconomic Feasibility of the Use of Antiviral Therapy in the Complex Treatment of Patients With Viral-Bacterial Moderate Community-Acquired Pneumonia

Ukrainian Pulmonology Journal
doi 10.31215/2306-4927-2019-106-4-11-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ukrainian Pulmonology Journal

Related search

Viral and Bacterial Aetiology of Community-Acquired Pneumonia in Adults

Influenza and other Respiratory Viruses
EnvironmentalPublic HealthEpidemiologyPulmonaryInfectious DiseasesRespiratory MedicineOccupational Health
2012English

Empiric Therapy of Community-Acquired Pneumonia

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Antibacterial Therapy of Community-Acquired Pneumonia in Children

CHILD`S HEALTH
2018English

Switch Therapy in Hospitalized Patients With Community-Acquired Pneumonia: Tigecycline vs. Levofloxacin

BMC Infectious Diseases
Infectious Diseases
2012English

Oxidative Metabolism of Neutrophils in Patients With Community-Acquired Pneumonia

Current Issues in Pharmacy and Medical Sciences
2016English

Adrenal Function in Patients With Community-Acquired Pneumonia

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2008English

Full-Course Oral Levofloxacin for Treatment of Hospitalized Patients With Community-Acquired Pneumonia

European Journal of Clinical Microbiology and Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2004English

Private Costs of Patients Hospitalized With Community-Acquired Pneumonia

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2005English

Advances in the Prevention, Management, and Treatment of Community-Acquired Pneumonia

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy